Fox R, Arnold DL Bar-Or A, et al. Effects of siponimod on MRI outcomes in patients with secondary progressive multiple sclerosis: results of the phase 3 EXPAND study. ECTRIMS 2017, 129.
Glatirameeracetaat: ook risico op anafylactische reacties lang na start behandeling
sep 2024 | Multipele Sclerose